JZP458 closes the asparaginase allergy gap
- PMID: 36795447
- DOI: 10.1182/blood.2022018395
JZP458 closes the asparaginase allergy gap
Comment on
-
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study.Blood. 2023 Feb 16;141(7):704-712. doi: 10.1182/blood.2022016923. Blood. 2023. PMID: 36108304 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous